ARTICLE | Clinical News
Anthrax Immune Globulin: Phase I/II started
March 23, 2009 7:00 AM UTC
Emergent BioSolutions began a double-blind, dose-escalation, U.S. Phase I/II trial to compare 3 dose levels of a single IV infusion of AIG vs. Gamunex immune globulin from Talecris Biotherapeutics I...